Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 32586
Titanium Dioxide Modified with Glutathione as Potential Drug Carrier with Reduced Toxic Properties

Authors: Olga Długosz, Jolanta Pulit-Prociak, Marcin Banach


The paper presents a process to obtain glutathione-modified titanium oxide nanoparticles. The processes were carried out in a microwave radiation field. The influence of the molar ratio of glutathione to titanium oxide and the effect of the fold of NaOH vs. stoichiometric amount on the size of the formed TiO2 nanoparticles was determined. The physicochemical properties of the obtained products were evaluated using dynamic light scattering (DLS), transmission electron microscope- energy-dispersive X-ray spectroscopy (TEM-EDS), low-temperature nitrogen adsorption method (BET), X-Ray Diffraction (XRD) and Fourier-transform infrared spectroscopy (FTIR) microscopy methods. The size of TiO2 nanoparticles was characterized from 30 nm to 336 nm. The release of titanium ions from the prepared products was evaluated. These studies were carried out using different media in which the powders were incubated for a specific time. These were: water, SBF and Ringer's solution. The release of titanium ions from modified products is weaker compared to unmodified titanium oxide nanoparticles. The reduced release of titanium ions may allow the use of such modified materials as substances in drug delivery systems.

Keywords: titanium dioxide, nanoparticles, drug carrier, glutathione

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 436


[1] D. Liu, Y. Bi, Controllable fabrication of hollow TiO2 spheres as sustained release drug carrier, Advanced Powder Technology, 2019, 30, 10, 2169-2177.
[2] S. Çeşmeli, C. B. Avci, Application of titanium dioxide (TiO2) nanoparticles in cancer therapies, J Drug Target, 2019, 27, 762-766.
[3] T. Wang, H. Jiang, L. Wan, Q. Zhao, T. Jiang, B. Wang, S. Wang, Potential application of functional porous TiO2 nanoparticles in light-controlled drug release and targeted drug delivery, Acta Biomaterialia, 2015, 13, 354-363.
[4] A. Leon, P. Reuquen, C. Garin, P. Segura, P. Vargas, P. Zapata, P. A. Orihuela, FTIR and Raman Characterization of TiO2 Nanoparticles Coated with Polyethylene Glycol as Carrier for 2-Methoxyestradiol, Applied Sciences, 2017, 7, 49, 1-9.
[5] S. Jafari, B. Mahyad, H. Hashemzadeh, S. Janfaza, T. Gholikhani and L. Tayebi, Biomedical Applications of TiO2 Nanostructures: Recent Advances, Int J Nanomedicine, 2020, 15, 3447-3470.
[6] Y. Liu, C. Xie, F. Zhang and X. Xiao, pH-Responsive TiO2 Nanotube Drug Delivery System Based on Iron Coordination, Journal of Nanomaterials, 2019, 2019, 1-7.
[7] S. Jafari, B. Mahyad, H. Hashemzadeh, S. Janfaza, T. Gholikhani, L. Tayebi, Biomedical Applications of TiO2 Nanostructures: Recent Advances, International Journal of Nanomedicine, 2020, 15, 3447-3470.